Several Chicago Cannabis Dispensaries Halt Adult-Use Sales Due to Supply Issues

Several Chicago Cannabis Dispensaries Halt Adult-Use Sales Due to Supply Issues

Minnesota’s two vertically integrated medical cannabis businesses are advocating for the legalization of smokable flower during the state’s 2020 legislative session in an effort to make the program more affordable for both businesses and patients.

The program has been slow to expand since its 2014 launch, partly due to the high costs associated with an extract-only market, according to Bill Parker, CEO for LeafLine Labs, one of the state’s two cannabis licensees. State law prohibits flower, leaving businesses no choice but to produce higher-priced, extract-based products such as oils, oral suspension, sublingual sprays, capsules and topicals.

“Throughout the years, what we’ve heard from patients and potential patients within the state is there are two major problems with the program as it currently sits,” Parker told Cannabis Business Times. “The two issues are access and affordability.”

LeafLine ramped up its lobbying efforts last year to support legislation to expand accessibility, and the law was ultimately revised to allow the state’s two licensed businesses to expand into eight dispensaries (called “care centers” in Minnesota). Previously, each licensee was allowed to operate four care centers.

Published at Mon, 06 Jan 2020 21:12:00 +0000

Comments are closed.